Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension-Reference-Cited by-同舟云学术

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension

Published:2010-03-17 Issue:4 Volume:69 Page:718-722
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Annals of the Rheumatic Diseases

Author:

Ruperto N.,Lovell D. J.,Cuttica R.,Woo P.,Meiorin S.,Wouters C.,Silverman E. D.,Balogh Z.,Henrickson M.,Davidson J.,Foeldvari I.,Imundo L.,Simonini G.,Oppermann J.,Xu S.,Shen Y.-K.,Visvanathan S.,Fasanmade A.,Mendelsohn A.,Martini A.,Giannini E. H.,

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When should the use of biological agents be considered in persistent oligoarticular juvenile idiopathic arthritis patients?;European Journal of Pediatrics;2024-03-30

2. Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review;Pediatric Rheumatology;2023-02-24

3. Alternative Biologic Therapy in Children Failing Conventional TNFα Inhibitors for Refractory, Noninfectious, Chronic Anterior Uveitis;American Journal of Ophthalmology;2022-12

4. Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review;2022-10-05

5. Emerging therapies for juvenile arthritis: agents in early clinical trials;Expert Opinion on Investigational Drugs;2022-09-08